CNS Pharmaceuticals

CNSP

Börsenwert 7,09 Mio. $

#	Name	Position	Handelswert	Veränderung Aktien	Anteils- änderung
1	1 Ikarian Capital Dallas, Texas	649.267 $	+378.000 $	+90.000	+196 %
2	2 ADAR1 Capital Management Austin, Texas	334.600 $	+294.000 $	+70.000	Neu
3	SCM 3 Stonepine Capital Management Bend, Oregon	198.719 $	-81.593 $	-19.427	-32 %
4	4 Boothbay Fund Management New York	64.645 $	–	–	–
5	5 Vanguard Fiduciary Trust Malvern, Pennsylvania	48.880 $	+42.949 $	+10.226	Neu
6	6 Vanguard Capital Management Malvern, Pennsylvania	33.427 $	+29.371 $	+6.993	Neu
7	7 UBS Group Zurich, Switzerland	6.983 $	+3.074 $	+732	+100 %
8	8 Tower Research Capital (TRC) New York	3.819 $	-2.146 $	-511	-39 %
9	9 Barclays London, United Kingdom	91 $	+80 $	+19	Neu
10	BC 10 Barrett & Company Providence, Rhode Island	38 $	–	–	–
11	11 Danske Bank Copenhagen K, Denmark	5 $	–	–	–
12	12 Geode Capital Management Boston, Massachusetts	–	-55.653 $	-23.189	Geschlossen
13	13 Sound Income Strategies Ft Lauderdale, Florida	–	-36 $	-16	Geschlossen
14	14 MAI Capital Management Independence, Ohio	–	-8 $	-3	Geschlossen
15	15 Caitong International Asset Management Hong Kong	–	-2 $	-1	Geschlossen
16	16 Citigroup New York	–	-2 $	-1	Geschlossen